141 related articles for article (PubMed ID: 30380885)
1. Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology.
Masuda H; Nakamura T; Noma Y; Harashima H
Mol Pharm; 2018 Dec; 15(12):5762-5771. PubMed ID: 30380885
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticulation of BCG-CWS for application to bladder cancer therapy.
Nakamura T; Fukiage M; Higuchi M; Nakaya A; Yano I; Miyazaki J; Nishiyama H; Akaza H; Ito T; Hosokawa H; Nakayama T; Harashima H
J Control Release; 2014 Feb; 176():44-53. PubMed ID: 24389133
[TBL] [Abstract][Full Text] [Related]
3. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy.
Ishii K; Kurita-Taniguchi M; Aoki M; Kimura T; Kashiwazaki Y; Matsumoto M; Seya T
Immunol Lett; 2005 May; 98(2):280-90. PubMed ID: 15860229
[TBL] [Abstract][Full Text] [Related]
4. Distribution of BCG-CWS-Loaded Nanoparticles in the Spleen After Intravenous Injection Affects Cytotoxic T Lymphocyte Activity.
Masuda H; Nakamura T; Harashima H
J Pharm Sci; 2020 Jun; 109(6):1943-1950. PubMed ID: 32070704
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.
Paik TH; Lee JS; Kim KH; Yang CS; Jo EK; Song CH
Vaccine; 2010 Nov; 28(50):7873-80. PubMed ID: 20937311
[TBL] [Abstract][Full Text] [Related]
6. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.
Nishida S; Tsuboi A; Tanemura A; Ito T; Nakajima H; Shirakata T; Morimoto S; Fujiki F; Hosen N; Oji Y; Kumanogoh A; Kawase I; Oka Y; Azuma I; Morita S; Sugiyama H
Medicine (Baltimore); 2019 Aug; 98(33):e16771. PubMed ID: 31415377
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
[TBL] [Abstract][Full Text] [Related]
8. [Development of a Drug Delivery System for Cancer Immunotherapy].
Nakamura T
Yakugaku Zasshi; 2016; 136(11):1477-1484. PubMed ID: 27803478
[TBL] [Abstract][Full Text] [Related]
9. Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model.
Nakamura T; Fukiage M; Suzuki Y; Yano I; Miyazaki J; Nishiyama H; Akaza H; Harashima H
J Control Release; 2014 Dec; 196():161-7. PubMed ID: 25315488
[TBL] [Abstract][Full Text] [Related]
10. Bacillus Calmette-Guérin cell-wall skeleton enhances the killing activity of cytotoxic lymphocyte-activated human dendritic cells transduced with the prostate-specific antigen gene.
Fujii R; Iwahashi M; Kikkawa K; Inagaki T; Kohjimoto Y; Ojima T; Mori T; Kuramoto T; Nishizawa S; Azuma I; Yamaue H; Shinka T; Hara I
BJU Int; 2009 Dec; 104(11):1766-73. PubMed ID: 20063450
[TBL] [Abstract][Full Text] [Related]
11. Antitumor Efficacy of Bacillus Calmette-Guerin Loaded Cationic Nanoparticles for Intravesical Immunotherapy of Bladder Tumor Induced Rat Model.
Erdoğar N; Iskit AB; Eroğlu H; Sargon MF; Mungan NA; Bilensoy E
J Nanosci Nanotechnol; 2015 Dec; 15(12):10156-64. PubMed ID: 26682462
[TBL] [Abstract][Full Text] [Related]
12. Development of immunoadjuvants for immunotherapy of cancer.
Azuma I; Seya T
Int Immunopharmacol; 2001 Jul; 1(7):1249-59. PubMed ID: 11460306
[TBL] [Abstract][Full Text] [Related]
13. Bacillus calmette-guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy.
Yuk JM; Shin DM; Song KS; Lim K; Kim KH; Lee SH; Kim JM; Lee JS; Paik TH; Kim JS; Jo EK
Autophagy; 2010 Jan; 6(1):46-60. PubMed ID: 19901560
[TBL] [Abstract][Full Text] [Related]
14. The restoration of suppressed T cell activities induced by 7,12-dimethylbenz[a]anthracene with an anti-tumor immunomodulator, BCG-cell wall skeleton.
Yamashita U; Ikegami R; Hamaoka T
Gan; 1982 Oct; 73(5):783-9. PubMed ID: 6219910
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant-mediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice.
Akazawa T; Masuda H; Saeki Y; Matsumoto M; Takeda K; Tsujimura K; Kuzushima K; Takahashi T; Azuma I; Akira S; Toyoshima K; Seya T
Cancer Res; 2004 Jan; 64(2):757-64. PubMed ID: 14744795
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin (BCG-CWS) for cervical cancer.
Shibata T; Takata E; Sakamoto J; Shioya A; Yamada S; Takakura M; Sasagawa T
Medicine (Baltimore); 2022 Dec; 101(52):e32481. PubMed ID: 36595982
[TBL] [Abstract][Full Text] [Related]
18. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
Miyauchi M; Murata M; Fukushima A; Sato T; Nakagawa M; Fujii T; Koseki N; Chiba N; Kashiwazaki Y
Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993
[TBL] [Abstract][Full Text] [Related]
19. The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.
Miyazaki J; Kawai K; Kojima T; Oikawa T; Joraku A; Shimazui T; Nakaya A; Yano I; Nakamura T; Harashima H; Akaza H
BJU Int; 2011 Nov; 108(9):1520-6. PubMed ID: 21314815
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral injection of BCG-CWS-pretreated dendritic cells following tumor cryoablation.
Kawamura N; Udagawa M; Fujita T; Sakurai T; Yaguchi T; Kawakami Y
Methods Mol Biol; 2014; 1139():145-53. PubMed ID: 24619677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
